News
Treatment with a spinal cord stimulation system reduced pain and restored sensory nerve function in a small cohort of ...
2mon
GlobalData on MSNGlobus Medical strengthens SCS market position with $250m Nevro dealBoston Scientific’s Wavewriter spinal cord stimulator systems, for example, gained access to a wider market after winning FDA approval for non-surgical back pain in February 2024. Looking ahead ...
A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.
Boston Scientific Corporation develops ... neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results